Sanofi inks deal with I-Mab; Wave discloses $175M offering on heels of DMD data

Plus, news about BioAge, Fulcrum Therapeutics and Arcutis Biotherapeutics:

Sanofi snags Greater China rights to CD73 antibody: The French pharma

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

A novel diagnostic model using machine learning (ML).

April 24, 2024

IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma

Use of intravenous immunoglobulin (IVIg) may substantially reduce the risk for severe infections in multiple myeloma patients treated with an anti-B-cell maturation antigen (BCMA) bispecific

September 30, 2023

Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences received approval from

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.